GlaxoSmithKline and Merck and Co. are each currently undertaking clinical testing of rotavirus vaccine candidates.

Source: Inpharma, Volume 1, Number 1353, 2002 , pp. 4-4(1)

Publisher: Adis International

Keywords: Children; Diarrhoea, prevention; Drug-discovery-technologies; GlaxoSmithKline; Infants; Merck-and-Co; Research-and-development; Rotavirus-infections, prevention; Rotavirus-vaccine, immunogenicity; Vaccines, immunogenicity

Language: English

Document Type: Short communication

Publication date: 2002-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers